Sun Pharma Looks to Rise in US with $10-billion Organon Buy
Published on: Jan. 19, 2026, 3:17 a.m. | Source: The Economic Times
Sun Pharmaceutical Industries Ltd, Indias largest drugmaker by market cap and revenue, is evaluating the acquisition of US-based Organon, a specialist in womens health with an expanding presence in the fast-emerging biosimilars space, people familiar with the development told ET.
